Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-10
1995-03-14
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514259, 514811, A61K 31505
Patent
active
053977823
ABSTRACT:
Method of treating addiction to alcohol and symptoms related to withdrawal of said alcohol comprising the administration of certain 4-[bis(halophenyl)methylene]-1-piperidinyl derivatives.
REFERENCES:
patent: 4847281 (1989-07-01), Tyers
Nabeshima, T. et al., Biochem Pharmacol 37(17): 3277-3284, 1988 (Abstract).
B. S. Neal et al.: "The serotonin.sub.2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective", Psychopharmacology, 100, No. 2, Feb. 1990, pp. 258-266.
J. Duysens et al., "Pharmacological suppresion of the hindlimb withdrawal reflex of the rat; a comparison between serotonergic antagonists and an adrenergic agonist", Arch. Int. Pharmacodyn. Ther., 290, No. 1, 1987, pp. 154-155.
S. L. Handley et al., "Ritanserin Reduces Morphine, and Clonidine, Withdrawal Tics", Brit. J. Pharmacol., 89, Proc. suppl., 1986, p. 647P.
Meert et al., "Ritanserin Reduces Abuse of Alcohol, Cocaine, and Fentanyl in Rats", Pharmacopsychology, 24, No. 5, Sep. 1991.
Meert et al., The preference for alcohol and cocaine is virtually abolished by the 5-HT.sub.2 receptor antagonist ritanserin, European Journal of Pharmacology, 183, Jul. 1990 (XIth International Congress of Pharmacology, Amsterdam, The Netherlands).
Dugovic et al., Effects of Ritanserin and Chlordiazepoxide on Sleep Alterations in Rats After Withdrawal From Chronic Cocaine Treatment, WFSRS Founding Congress (Abstract form for Sleep Research), Cannes, France, Sep. 21-25, 1991.
Meert et al., Ritanserin reduces alcohol preference and alcohol intake in rats given the choice between 3% alcohol and water, Pharmacol. (Life Sci. Adv.) 1990, 9: 63-69.
The Merck Index, (11th Ed.), Budavari et al. (Editors), "ondansetron", 1989, p. 1082.
P. 30 of SCRIP, No. 1287/8, Apr. 6/8th, 1988.
Meert et al., Psychopharmacology of Ritanserin: Comparison with Chlordiazepoxide, Drug Development Research 18:119-144 (1989).
Nomikos et al., "Effects of Ritanserin on the rewarding properties of d-Amphetamine, Morphine and Diazepam Revealed by Conditioned Place Preference in Rats", Pharmacology Biochemistry & Behavior, vol. 30, pp. 853-858 (1988).
Henley III Raymond J.
Janssen Pharmaceutica N.V.
Metz Charles J.
Moezie M.
LandOfFree
Method of treating addiction to alcohol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating addiction to alcohol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating addiction to alcohol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713883